Philips Expands its uGrow Digital Parenting Platform with the Acquisition of Health & Parenting Ltd

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired Health & Parenting Ltd, a leading London-based developer of healthcare and family-related mobile applications for expectant and new parents. Health & Parenting's apps will enhance Philips' uGrow* digital parenting platform and strengthen Philips' offering in pregnancy and parenting. Financial details of the transaction were not disclosed.

Health & Parenting creates easy-to-use and helpful apps to guide expecting parents through pregnancy and into parenthood. Its leading product is the Pregnancy+ app, which is one of the world’s most downloaded pregnancy apps with approximately 12 million downloads from the Apple App Store and Google Play Store.

Health & Parenting’s applications will be integrated into Philips’ uGrow digital parenting platform, which captures data from connected devices, such as Philips Avent smart baby monitor and Philips Avent smart ear thermometer, and provides personalized feedback and advice. The uGrow platform also leverages the open infrastructure of Philips’ Health Suite Digital Platform, a cloud-enabled connected health ecosystem of devices, apps and digital tools.

"This acquisition fits perfectly in our digital strategy to help expectant and new parents understand and support their baby's healthy development, through a series of connected digital products with the uGrow application at the core," said Egbert van Acht, Business Leader Health & Wellness at Philips. "With Health & Parenting, we will strengthen our digital offering in pregnancy and parenting, and increase the scale of our global parenting platform that provides consumer and professional care."

"We are delighted to join Philips and continue our successful app development work as part of a strong global team," said John Miles, CEO of Health & Parenting. "We set up Health & Parenting to make a positive difference to the lives of millions of pregnant women and new parents worldwide. In Philips we found a like-minded organization and we look forward to the integration of our parenting apps into Philips' uGrow platform, and to support millions of its users through each family stage."

* The uGrow app is registered as a medical device in the European Union countries under the European Union Regulation Council Directive 93/42/EEC

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...